Quick Answer: Retatrutide is an investigational weight loss drug from Eli Lilly that targets three hormone receptors (GLP-1, GIP, and glucagon) one more than Mounjaro and two more than Ozempic
This matched research bundle combines CJC-1295 with DAC and Ipamorelin in a convenient paired format for laboratory and analytical use
Heart health According to a 2024 review, L-carnitine may significantly impact heart health
Individuals with type 2 diabetes and established cardiovascular disease represent a key group, as chronic inflammation plays a role in atherosclerotic progression
These alternative delivery methods have their own preparation and storage requirements
Given the tendency of these drugs to quiet food noise, and reduce cravings, the treatment of addiction is another area where scientists see a lot of potential for GLP-1s